PLIANT THERAPEUTICS, INC. Payments for Restructuring
PLIANT THERAPEUTICS, INC. (PLRX) reported Payments for Restructuring of $3.80 million for the 8-month period ending 2025-12-31, per its 10-K filed 2026-03-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-08-11
- PLIANT THERAPEUTICS, INC. payments for restructuring for the quarter ending 2025-09-30 was $600.00K.
| Period end | Payments for Restructuring 1 month | Payments for Restructuring 2 month | Payments for Restructuring 3 month | Payments for Restructuring 8 month | Payments for Restructuring 9 month |
|---|---|---|---|---|---|
| 2025-12-31 | $2.50M 10-Q · filed 2026-08-11 | $3.80M 10-K · filed 2026-03-11 | |||
| 2025-09-30 | $600.00K 10-Q · filed 2025-11-06 | $3.80M 10-Q · filed 2025-11-06 | |||
| 2025-06-30 | $3.20M 10-Q · filed 2025-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |